LifeMD (LFMD) News Today $5.97 -0.13 (-2.13%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Royce & Associates LP Acquires 214,950 Shares of LifeMD, Inc. (NASDAQ:LFMD)Royce & Associates LP boosted its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 23.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,115,991 shares of the company's stock after purchasing an additional 214,950 shMarch 20, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Sees Significant Growth in Short InterestLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 6,400,000 shares, a growth of 25.2% from the February 13th total of 5,110,000 shares. Based on an average trading volume of 1,060,000 shares, the days-to-cover ratio is currently 6.0 days. Currently, 18.8% of the shares of the company are sold short.March 18, 2025 | marketbeat.comInsider Selling: LifeMD, Inc. (NASDAQ:LFMD) CMO Sells 30,000 Shares of StockLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CMO Jessica Friedeman sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.66, for a total transaction of $169,800.00. Following the completion of the transaction, the chief marketing officer now directly owns 170,000 shares of the company's stock, valued at approximately $962,200. This trade represents a 15.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.March 18, 2025 | marketbeat.comJessica Friedeman Sells 30,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockMarch 18, 2025 | insidertrades.comFirst Eagle Investment Management LLC Makes New Investment in LifeMD, Inc. (NASDAQ:LFMD)First Eagle Investment Management LLC acquired a new stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 50,356 shares of the company's stock, valued at approximatelMarch 17, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Grows Stake in LifeMD, Inc. (NASDAQ:LFMD)Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 21.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 931,294 shares of the company's stock afteMarch 17, 2025 | marketbeat.comB. Riley Estimates LifeMD's Q1 Earnings (NASDAQ:LFMD)March 16, 2025 | americanbankingnews.comEquities Analysts Set Expectations for LifeMD Q1 EarningsLifeMD, Inc. (NASDAQ:LFMD - Free Report) - Analysts at B. Riley issued their Q1 2025 earnings estimates for shares of LifeMD in a research report issued on Tuesday, March 11th. B. Riley analyst A. Schock anticipates that the company will post earnings per share of ($0.07) for the quarter. B. RileMarch 15, 2025 | marketbeat.comB. Riley Upgrades LifeMD (NASDAQ:LFMD) to Strong-BuyB. Riley raised LifeMD to a "strong-buy" rating in a report on Tuesday.March 14, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Price Target Raised to $14.00 at HC WainwrightHC Wainwright lifted their price target on LifeMD from $12.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday.March 13, 2025 | marketbeat.comLifeMD's (LFMD) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $15.00 price target on shares of LifeMD in a research note on Tuesday.March 12, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Announces Earnings Results, Beats Estimates By $0.02 EPSLifeMD (NASDAQ:LFMD - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02.March 11, 2025 | marketbeat.comLake Street Keeps Their Buy Rating on LifeMD (LFMD)March 11, 2025 | markets.businessinsider.comLifeMD, Inc. (LFMD) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | seekingalpha.comLifeMD Reports Fourth Quarter 2024 ResultsMarch 10, 2025 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from AnalystsLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating toMarch 7, 2025 | marketbeat.comTelehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer ZepboundMarch 6, 2025 | reuters.comLifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP ZepboundMarch 6, 2025 | globenewswire.comLifeMD to Participate in the KeyBanc Capital Markets Healthcare ForumMarch 5, 2025 | globenewswire.comLifeMD (LFMD) to Release Earnings on MondayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Monday, March 10, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669769)March 3, 2025 | marketbeat.comLifeMD to Report Fourth Quarter 2024 Financial Results on March 10February 25, 2025 | globenewswire.comLifeMD announces expansion into behavioral health marketFebruary 24, 2025 | markets.businessinsider.comLifeMD® Announces Entry Into the Behavioral Health MarketFebruary 24, 2025 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) CEO Justin Schreiber Sells 50,000 SharesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CEO Justin Schreiber sold 50,000 shares of the business's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $7.55, for a total value of $377,500.00. Following the transaction, the chief executive officer now owns 2,653,715 shares of the company's stock, valued at approximately $20,035,548.25. This trade represents a 1.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.February 22, 2025 | marketbeat.comInsider Selling: LifeMD, Inc. (NASDAQ:LFMD) CEO Sells 50,000 Shares of StockFebruary 22, 2025 | insidertrades.comCraig-Hallum Sticks to Its Buy Rating for LifeMD (LFMD)February 14, 2025 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have issued a buy ratingFebruary 10, 2025 | marketbeat.comJPMorgan Chase & Co. Has $462,000 Position in LifeMD, Inc. (NASDAQ:LFMD)JPMorgan Chase & Co. boosted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 496.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,173 shares of the company's stock after buyingJanuary 29, 2025 | marketbeat.comLifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 28, 2025 | globenewswire.comMirador Capital Partners LP Grows Stake in LifeMD, Inc. (NASDAQ:LFMD)Mirador Capital Partners LP increased its stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 139.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 106,059 shares of the company's stock after purchasing an additional 61,73January 16, 2025 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Moderate Buy" by AnalystsShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation onJanuary 16, 2025 | marketbeat.comLifeMD (NASDAQ:LFMD) Given New $7.00 Price Target at KeyCorpKeyCorp cut their price objective on LifeMD from $10.00 to $7.00 and set an "overweight" rating on the stock in a research report on Wednesday.January 8, 2025 | marketbeat.comJustin Schreiber Sells 25,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) StockJanuary 7, 2025 | insidertrades.comLifeMD, Inc. (NASDAQ:LFMD) CEO Sells $129,750.00 in StockLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) CEO Justin Schreiber sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $5.19, for a total transaction of $129,750.00. Following the sale, the chief executive officer now directly owns 2,703,715 shares in the company, valued at approximately $14,032,280.85. This represents a 0.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.January 6, 2025 | marketbeat.comState Street Corp Buys 192,861 Shares of LifeMD, Inc. (NASDAQ:LFMD)State Street Corp boosted its position in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 20.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,155,495 shares of the company's stock after acquiring an additional 192,861 shares during the period. State StDecember 29, 2024 | marketbeat.comLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockDecember 24, 2024 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. ThDecember 22, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Now Covered by Analysts at Lake Street CapitalLake Street Capital began coverage on shares of LifeMD in a research report on Tuesday. They set a "buy" rating and a $12.00 price objective for the company.December 10, 2024 | marketbeat.comLifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and DistributionDecember 5, 2024 | markets.businessinsider.comLifeMD initiated with a Neutral at MizuhoDecember 4, 2024 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by AnalystsShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are presently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target amoNovember 27, 2024 | marketbeat.comRoyce & Associates LP Has $4.72 Million Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD)Royce & Associates LP lifted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 901,041 shares of the company's stNovember 19, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires 108,822 Shares of LifeMD, Inc. (NASDAQ:LFMD)Los Angeles Capital Management LLC boosted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 852.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 121,585 shares of the company's stock afteNovember 17, 2024 | marketbeat.comLifeMD (LFMD) Gets a Buy from Craig-HallumNovember 15, 2024 | markets.businessinsider.comLifeMD to Participate in Three Investor Conferences During NovemberNovember 12, 2024 | markets.businessinsider.comStrong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite ChallengesNovember 11, 2024 | markets.businessinsider.comLifeMD, Inc.: LifeMD Reports Third Quarter 2024 ResultsNovember 11, 2024 | finanznachrichten.deLifeMD (NASDAQ:LFMD) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $12.00 price target on shares of LifeMD in a report on Monday.November 11, 2024 | marketbeat.comLifeMD, Inc. (LFMD) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comLifeMD backs FY24 revenue view at least $205M, consensus $206MNovember 9, 2024 | markets.businessinsider.com Remove Ads Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address LFMD Media Mentions By Week LFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFMD News Sentiment▼1.860.63▲Average Medical News Sentiment LFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFMD Articles This Week▼32▲LFMD Articles Average Week Remove Ads Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CareDx News Today Fortrea News Today The Pennant Group News Today Castle Biosciences News Today Fulgent Genetics News Today Auna News Today Talkspace News Today Enhabit News Today InnovAge News Today Celcuity News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFMD) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
